ADC Therapeutics SA
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -24.0% | -13.2% | +20.7% | -6.1% | -7.8% | -15.4% | +18.0% | -9.9% | +11.5% | -9.8% | -4.2% | |
| – | -10.5% | -13.7% | +22.5% | -6.3% | -7.7% | -16.1% | +23.6% | -9.9% | +6.7% | -9.7% | -5.4% | |
| – | -10.2% | -15.9% | +28.1% | -8.6% | -8.5% | -22.4% | +35.9% | -11.3% | +11.3% | -11.6% | -5.2% | |
| – | -10.2% | -15.9% | +28.1% | -8.6% | -8.5% | -22.4% | +35.9% | -11.3% | +11.3% | -11.6% | -5.2% | |
| – | +18.9% | -7.9% | -1.4% | +5.1% | -15.5% | +56.3% | -17.6% | -12.5% | +27.0% | +6.6% | -9.7% | |
| – | -28.8% | -1.1% | -5.0% | +5.8% | +14.4% | -5.1% | +1.8% | +1.6% | -76.8% | +14.1% | +3.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.5% | -0.1% | +0.2% | +3.5% | +0.7% | -2.6% | +2.0% | +1.4% | -3.6% | -0.2% | -0.1% | |
| – | -13.5% | -6.9% | -8.5% | +17.4% | +18.9% | -28.2% | +11.8% | -4.0% | +13.1% | -3.6% | +27.7% | |
| – | -90.7% | -2.4% | -1.2% | +4.5% | -7.3% | -0.2% | +31.0% | -47.9% | +221.5% | +54.5% | +33.3% | |
| – | +73.4% | -8.1% | -25.2% | +34.2% | +25.4% | -13.5% | -38.3% | -15.6% | +13.0% | -42.3% | +141.0% | |
| – | +15.4% | +0.4% | +0.4% | +0.5% | -0.5% | +0.2% | +0.6% | +0.6% | -2.4% | -1.3% | -0.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.3% | +15.9% | +9.5% | +0.5% | +1.7% | +6.1% | +20.0% | +10.2% | +2.6% | +0.6% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.